ALMR Stock: Price, Earnings History and SEC Filings
Alamar Biosciences, Inc. (ALMR) last traded at $30.60, down 10.11% on the latest session and down 10.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.22 against an analyst estimate of $-0.36, a beat of 38.9%.
$30.60 -10.11%
1 month-10.18%
52-week high$39.61
52-week low$18.85
Volume740,069
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ALMR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $-0.22 | $-0.36 | +38.89% |
ALMR beat the analyst EPS estimate in 1 of its last 1 reported quarters. Source: Nasdaq.
Latest SEC filings for ALMR
SEC filing data is not available right now. You can search for ALMR on SEC EDGAR.
ALMR news
- Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar TechnologyOct 28, 2026 · finance.yahoo.com
- Kardigan And 2 Founder Run Stocks To OwnOct 20, 2026 · finance.yahoo.com
About Alamar Biosciences, Inc.
Alamar Biosciences, Inc. (ALMR) is a US-listed public company on Nasdaq.